NCT00075348View on ClinicalTrials.gov

Genetic Study to Identify Gene Mutations in Participants Previously Enrolled in Clinical Trial NCI-99-C-0053 Who Have Von Hippel-Lindau Syndrome or Are at Risk for Von Hippel-Lindau Syndrome

CompletedOBSERVATIONAL
Enrollment

260

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Kidney CancerVon Hippel-lindau Syndrome
Interventions
GENETIC

mutation analysis

Trial Locations (1)

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office, Bethesda

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

National Institutes of Health Clinical Center (CC)

NIH

NCT00075348 - Genetic Study to Identify Gene Mutations in Participants Previously Enrolled in Clinical Trial NCI-99-C-0053 Who Have Von Hippel-Lindau Syndrome or Are at Risk for Von Hippel-Lindau Syndrome | Biotech Hunter | Biotech Hunter